AIM ImmunoTech
Thomas K. Equels was named Chief Executive Officer in February 2016, served as President since August 2015, has been a Director since 2008 and presently serves as AIM ImmunoTech’s Executive Vice Chairman.
This person is not in any offices
AIM ImmunoTech
AIM ImmunoTech Inc., an immuno-pharma company headquartered in Ocala, Florida, is focused on the research and development of therapeutics to treat multiple types of cancers, as well as immune-deficiency disorders.